Amendment No. 9 to Schedule 13D for NeueHealth, Inc.

This Amendment No. 9 to Schedule 13D, filed on October 6, 2025, pertains to the common stock of NeueHealth, Inc. The filing is made by New Enterprise Associates (NEA) and its affiliated entities, including NEA 15, NEA 16, NEA 17, and NEA 18 Venture Growth Equity, among others. The amendment provides updates on the ownership and transactions involving NeueHealth's common stock. Key events include the entry into an Incremental Credit Agreement and Warrantholders Agreement on September 30, 2025, which facilitated incremental loans of $37.3 million by the NEA Lenders. Additionally, the filing details the consummation of a merger on October 2, 2025, where Merger Sub merged with NeueHealth, resulting in NeueHealth becoming a wholly owned subsidiary of NH Holdings 2025, Inc. The merger led to the cancellation of shares and the issuance of limited partnership interests in Ultimate Parent. The filing also notes the delisting of NeueHealth's common stock from the NYSE and the deregistration of the stock under Section 12(b) of the Exchange Act.